An estimated 30 million Americans are affected by chronic obstructive pulmonary disease (COPD), but surprisingly, only 17 million have received a diagnosis. Texas alone accounts for 1.2 million of ...
Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...
Since the program’s inception, the Temple Healthy Chest Initiative has offered low-dose computed tomography (LDCT) scans to detect lung cancer and other conditions at an earlier stage. As of October ...
Smoking is the primary cause, but long-term exposure to air pollutants and genetic factors also contribute. COPD has no cure, but treatments like medications, oxygen therapy, and lifestyle changes can ...
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.